An independent panel on evidence for action against AMR (IPEA) is needed to review science and raise AMR’s political profile. This brief explores two potential governance models for an IPEA's implementation and the potential benefits.
In April 2024, the Bellagio Group for Accelerating AMR Action, made up of global health researchers, policymakers, and civil society representatives met to identify unifying global goals for AMR.
Highlights for the inaugural year of the AMR Policy Accelerator.
How has the COVID-19 pandemic impacted antimicrobial use (AMU) and antimicrobial resistance (AMR)? As more data become available, the picture is becoming clearer.
Can WHO’s pandemic instrument be designed to address a wider range of pandemic threats? The Policy Accelerator advises on how the pandemic instrument could be made more comprehensive.
Antimicrobial resistance has generated an unprecedented amount of global attention since the launch of the Global Action Plan on AMR. Our research explores how global commitments on AMR have changed and adapted since 2015.
The Paris Agreement successfully mobilized collective action to protect a shared global common-pool resource and mitigate and adapt to the impacts of climate change. What are the takeaways for managing AMR?
